Alvotech Sa

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$3.26

+0.13 (+4.15%)

As of Mar 25, 1:46 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 75%

Hold 2 17%

Sell 1 8%

Price Target

Analyst Price Target +873.0% upside

Low Target $22.31

Average Target $31.72

High Target $46.94

Current Price $3.26

Current
$3.26

Target
$31.72

$22.31 $31.72 avg $46.94

Scenario Analysis

Bear Case

$22.31

584.4%

Low target

Base Case

$31.72

+873.0%

Avg target

Bull Case

$46.94

+1,339.9%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$11.85

-72.5% from high

52-Week Low

$3.42

+-4.7% from low

Target vs 52W High

$31.72

+167.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%